Corcept Therapeutics Incorporated (CORT) vs Twist Bioscience Corporation (TWST)
- Corcept Therapeutics Incorporated CORT 72.63 +1.40%
- Twist Bioscience Corporation TWST 119.38 −1.02%
Corcept Therapeutics Incorporated and Twist Bioscience Corporation are both Biotechnology companies. Corcept Therapeutics Incorporated and Twist Bioscience Corporation are of similar size ($7.9B and $7.8B). Twist Bioscience Corporation has negative trailing earnings, so its P/E is not meaningful; Corcept Therapeutics Incorporated trades at 47.8×. Corcept Therapeutics Incorporated grew revenue faster over the last twelve months: 30.0% against 19.2%. Corcept Therapeutics Incorporated has the higher net margin (16.5% vs −31.7%) and the higher return on invested capital (15.0% vs −30.8%). Across the 19 metrics below, Corcept Therapeutics Incorporated leads on 16 and Twist Bioscience Corporation on 3.
Valuation
Profitability
| Metric | CORT | TWST | Biotechnology median |
|---|---|---|---|
| Gross margin | 98.54% | 51.97% | 68.51% |
| Operating margin | 11.51% | (33.58%) | 0.00% |
| Net margin | 16.54% | (31.66%) | 0.00% |
| Free cash flow margin | 20.20% | (22.15%) | 0.00% |
| Return on equity | 21.74% | (29.59%) | (51.96%) |
| Return on assets | 17.16% | (20.78%) | (46.06%) |
| Return on invested capital | 14.97% | (30.83%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack